Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471207 · ClinicalTrials.gov registry record · Phase 1
Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT04471207 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 40 participants.
The verdict
NCT04471207, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Posttraumatic stress disorder (PTSD) is a debilitating mental health condition that increases suicide risk and affects up to 20% of military veterans and 8% of the general population. Prolonged Exposure (PE) is a highly effective behavioral (talk therapy) intervention for PTSD. However, dropout rates are high (25-30%) and an estimated one-third of patients who complete PE still report symptoms of PTSD at the end of treatment. This study directly addresses these limitations by using a clinical trial to evaluate the ability of an innovative technology system to improve PE therapy for veterans with PTSD.
Interventions
- DEVICE Therapist Guided Prolonged Exposure with BioWare Device
- DEVICE Record Only Prolonged Exposure with BioWare Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2022-03-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471207
The ClinicalTrials.gov registry entry for NCT04471207 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Therapist Guided Prolonged Exposure with BioWare Device is the first listed.
NCT04471207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04471207 about?
NCT04471207 is a clinical study titled "Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial". Posttraumatic stress disorder (PTSD) is a debilitating mental health condition that increases suicide risk and affects up to 20% of military veterans and 8% of the general population. Prolonged Exposure (PE) is a highly effective behavioral (talk therapy) intervention for PTSD. However, dropout rate...
What is the current status of trial NCT04471207?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2020-06-08. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT04471207?
The interventions under investigation include: Therapist Guided Prolonged Exposure with BioWare Device (DEVICE), Record Only Prolonged Exposure with BioWare Device (DEVICE).
Who is sponsoring clinical trial NCT04471207?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.